Outlook Therapeutics, Inc. (OTLK) financial statements and ratios from SEC XBRL: revenue $1.41M (TTM), net margin -4416.2%, revenue growth 56.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.41M |
| Net Margin | -4416.2% |
| Revenue Growth (YoY) | 56.0% |
| EPS Growth (YoY) | -55.9% |
| Altman Z-Score | -58.81 (distress) |
| Sector P/E (Healthcare) | 21.7 |
OTLK overview · OTLK earnings · OTLK KPIs · OTLK investor relations · OTLK ownership · OTLK peers · OTLK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.